The present invention relates to compositions and methods for treatment of disease. More particularly, the present invention relates to anti-IL-1ß and anti-IL-18 antibodies, including anti-IL-1ß and anti-IL-18 bispecific antibodies, and methods of treating disease using such antibodies.